Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biomed Pharmacother ; 158: 114070, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36526536

RESUMEN

Stauprimide, a semi-synthetic derivative of staurosporine, is known mainly for its potent differentiation-enhancing properties in embryonic stem cells. Here, we studied the effects of stauprimide in cell growth and migration of triple-negative breast cancer cells in vitro, evaluating its potential antitumoral activity in an orthotopic mouse model of breast cancer in vivo. Our results from survival curves, EdU incorporation, cell cycle analysis and annexin-V detection in MDA-MB-231 cells indicated that stauprimide inhibited cell proliferation, arresting cell cycle in G2/M without induction of apoptosis. A decrease in the migratory capability of MDA-MB-231 was also assessed in response to stauprimide. In this work we pointed to a mechanism of action of stauprimide involving the modulation of ERK1/2, Akt and p38 MAPK signalling pathways, and the downregulation of MYC in MDA-MB-231 cells. In addition, orthotopic MDA-MB-231 xenograft and 4T1 syngeneic models suggested an effect of stauprimide in vivo, increasing the necrotic core of tumors and reducing metastasis in lung and liver of mice. Together, our results point to the promising role of stauprimide as a putative therapeutic agent in triple-negative breast cancer.


Asunto(s)
Neoplasias de la Mama , Neoplasias de la Mama Triple Negativas , Humanos , Animales , Ratones , Femenino , Neoplasias de la Mama Triple Negativas/patología , Línea Celular Tumoral , Ciclo Celular , Proliferación Celular , Neoplasias de la Mama/tratamiento farmacológico , División Celular , Apoptosis
2.
Br J Pharmacol ; 173(12): 1966-87, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27018653

RESUMEN

BACKGROUND AND PURPOSE: Lymphangiogenesis is an important biological process associated with the pathogenesis of several diseases, including metastatic dissemination, graft rejection, lymphoedema and other inflammatory disorders. The development of new drugs that block lymphangiogenesis has become a promising therapeutic strategy. In this study, we investigated the ability of toluquinol, a 2-methyl-hydroquinone isolated from the culture broth of the marine fungus Penicillium sp. HL-85-ALS5-R004, to inhibit lymphangiogenesis in vitro, ex vivo and in vivo. EXPERIMENTAL APPROACH: We used human lymphatic endothelial cells (LECs) to analyse the effect of toluquinol in 2D and 3D in vitro cultures and in the ex vivo mouse lymphatic ring assay. For in vivo approaches, the transgenic Fli1:eGFPy1 zebrafish, mouse ear sponges and cornea models were used. Western blotting and apoptosis analyses were carried out to search for drug targets. KEY RESULTS: Toluquinol inhibited LEC proliferation, migration, tubulogenesis and sprouting of new lymphatic vessels. Furthermore, toluquinol induced apoptosis of LECs after 14 h of treatment in vitro, blocked the development of the thoracic duct in zebrafish and reduced the VEGF-C-induced lymphatic vessel formation and corneal neovascularization in mice. Mechanistically, we demonstrated that this drug attenuates VEGF-C-induced VEGFR-3 phosphorylation in a dose-dependent manner and suppresses the phosphorylation of Akt and ERK1/2. CONCLUSIONS AND IMPLICATIONS: Based on these findings, we propose toluquinol as a new candidate with pharmacological potential for the treatment of lymphangiogenesis-related pathologies. Notably, its ability to suppress corneal neovascularization paves the way for applications in vascular ocular pathologies.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Hidroquinonas/farmacología , Linfangiogénesis/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Factor C de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Receptor 3 de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Relación Estructura-Actividad , Pez Cebra
3.
J Biol Regul Homeost Agents ; 25(1): 13-20, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21382269

RESUMEN

Serotonin is an extracellular mediator recognized by seven different types of receptors, thus giving rise to pleiotropic intracellular responses. One of these responses is the activation of proliferation for a number of cell types. The induction of proliferation of otherwise quiescent endothelial cells is a key step of angiogenesis. Previously published work concerning the effect of serotonin on endothelial cell proliferation is controversial. The present work is aimed to re-evaluate the mitogenic role of serotonin on endothelial cells, since a pro-angiogenic role for serotonin could be hypothesized if its mitogenic potential on these cells were confirmed. By using three different types of endothelial cells and three experimental approaches, we demonstrate that serotonin cannot be considered a general mitogen for endothelial cells.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Células Endoteliales/metabolismo , Neovascularización Fisiológica/efectos de los fármacos , Agonistas de Receptores de Serotonina/farmacología , Serotonina/farmacología , Animales , Bovinos , Células Cultivadas , Células Endoteliales/citología , Mitógenos/metabolismo , Mitógenos/farmacología , Neovascularización Fisiológica/fisiología , Serotonina/metabolismo , Agonistas de Receptores de Serotonina/metabolismo
4.
Cell Mol Life Sci ; 63(24): 3083-9, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17131052

RESUMEN

The present study identified aloe-emodin (AE, a hydroxyanthraquinone from Aloe vera and other plants) as a new anti-angiogenic compound with inhibitory effects in an in vivo angiogenesis assay and evaluates its effects on specific key steps of the angiogenic process. AE inhibits endothelial cell proliferation, but this effect is not cell specific, since AE also inhibits tumor cell proliferation. Cell migration and invasion are not remarkably affected by AE. On the other hand, AE has different effects on endothelial and tumor cell gelatinases. Two main targets of the pharmacological action of AE as an anti-angiogenic compound seem to be urokinase secretion and tubule formation of endothelial cells. Finally, AE produces a remarkable photocytotoxic effect on tumor cells. Taken together, our data indicate that AE can behave both as an anti-tumor and an anti-angiogenic compound and suggest that AE could be a candidate drug for photodynamic therapy.


Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Emodina/farmacología , Células Endoteliales/efectos de los fármacos , Matriz Extracelular/efectos de los fármacos , Neovascularización Patológica/terapia , Animales , Antraquinonas , Bovinos , Diferenciación Celular , Línea Celular , Movimiento Celular , Proliferación Celular , Pollos , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Matriz Extracelular/metabolismo , Humanos , Estructura Molecular , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
5.
Cell Mol Life Sci ; 61(17): 2224-43, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15338053

RESUMEN

Endothelial cells receive multiple information from their environment that eventually leads them to progress along all the stages of the process of formation of new vessels. Angiogenic signals promote endothelial cell proliferation, increased resistance to apoptosis, changes in proteolytic balance, cytoskeletal reorganization, migration and, finally, differentiation and formation of a new vascular lumen. We aim to review herein the main signaling cascades that become activated in angiogenic endothelial cells as well as the opportunities of modulating angiogenesis through pharmacological interference with these signaling mechanisms. We will deal mainly with the mitogen-activated protein kinases pathway, which is very important in the transduction of proliferation signals; the phosphatidylinositol-3-kinase/protein kinase B signaling system, particularly essential for the survival of the angiogenic endothelium; the small GTPases involved in cytoskeletal reorganization and migration; and the kinases associated to focal adhesions which contribute to integrate the pathways from the two main sources of angiogenic signals, i.e. growth factors and the extracellular matrix.


Asunto(s)
Células Endoteliales/fisiología , Neovascularización Fisiológica , Transducción de Señal , Animales , Diferenciación Celular , Movimiento Celular , Supervivencia Celular , Receptores ErbB/fisiología , Matriz Extracelular/metabolismo , GTP Fosfohidrolasas/fisiología , Humanos , Proteínas Quinasas Activadas por Mitógenos/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Proteínas Proto-Oncogénicas c-met/fisiología , Receptor 2 de Factores de Crecimiento Endotelial Vascular/fisiología
6.
Biochem Biophys Res Commun ; 301(2): 540-4, 2003 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-12565896

RESUMEN

The impairment of homocysteine metabolism has been related to several disorders and diseases. Recently, homocysteine has been shown to inhibit key steps of angiogenesis, including endothelial cell proliferation, invasion, and remodeling of the extracellular matrix. Since these are also key steps in tumor invasion and metastasis, it can be hypothesized that homocysteine can also interfere in these processes. Therefore, we studied the effects of homocysteine on tumor proliferation and invasion, as well as on urokinase, a key extracellular matrix-degrading protease, using a model human tumor cell line. This study demonstrates that, in fact, homocysteine inhibits HT-1080 proliferation and invasion, and is a potent inhibitor of tumor cell urokinase expression.


Asunto(s)
División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Fibrosarcoma/patología , Homocisteína/farmacología , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Colágeno , Medio de Cultivo Libre de Suero , Combinación de Medicamentos , Fibrosarcoma/enzimología , Fibrosarcoma/metabolismo , Humanos , Laminina , Invasividad Neoplásica , Proteoglicanos , Células Tumorales Cultivadas
7.
Anticancer Res ; 21(5): 3457-60, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11848509

RESUMEN

We have re-evaluated the selectivity of fumagillin against endothelial cell proliferation and compared it to the reported selectivity of its potent analog TNP-470. We showed that fumagillin does not inhibit endothelial cell proliferation in a specific manner, but on the contrary it inhibits the proliferation of other cell types at the same range of concentrations. Furthermore, the IC50 values of fumagillin for endothelial cells are two orders of magnitude higher than those values reported for TNP-470 on endothelial cells; on the contrary, the IC50 value of fumagillin for human breast cancer MDA-MB231 cells is four orders of magnitude lower than the value reported for TNP-470 on the same cell line.


Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Endotelio Vascular/efectos de los fármacos , Ácidos Grasos Insaturados/farmacología , Células 3T3/citología , Células 3T3/efectos de los fármacos , Animales , Aorta/citología , Aorta/efectos de los fármacos , Bovinos , División Celular/efectos de los fármacos , Células Cultivadas , Ciclohexanos , Relación Dosis-Respuesta a Droga , Endotelio Vascular/citología , Humanos , Concentración 50 Inhibidora , Ratones , O-(Cloroacetilcarbamoil) Fumagilol , Especificidad de Órganos , Sesquiterpenos/farmacología , Células Tumorales Cultivadas
8.
Anticancer Res ; 20(3A): 1691-4, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10928093

RESUMEN

BACKGROUND: Ehrlich ascites tumor is an experimental tumor model very suitable for performing comparative studies relating its growth in vitro and in vivo. We used this tumor model to study the potential modulatory effects of genistein and 2-methoxyestradiol, two anti-angiogenic compounds, on the proteolytic balance MMP/TIMP. Ehrlich cells grown in vitro secreted MMP-9, MMP-2 and two TIMPs; the treatment with either of the anti-angiogenic compounds here tested stimulated all these activities, but the increase in TIMPs activities of genistein-treated cells were higher than those of MMPs, thus inducing a decrease in the proteolytic balance. On the other hand, Ehrlich cells growing in vivo did not produce any detectable TIMP activity, but accumulated MMP-9 and MMP-2 during tumor growth. Both compounds induced significant decrease of MMPs activity when tumor cells were actively proliferating. It was concluded that both genistein and 2-methoxyestradiol could shift the proteolytic balance MMP/TIMP towards antiproteolysis in media or ascitic fluid conditioned by actively growing Ehrlich cells.


Asunto(s)
Carcinoma de Ehrlich/enzimología , Inhibidores Enzimáticos/farmacología , Estradiol/análogos & derivados , Estradiol/farmacología , Genisteína/farmacología , Inhibidores de la Metaloproteinasa de la Matriz , Inhibidores Tisulares de Metaloproteinasas/metabolismo , 2-Metoxiestradiol , Animales , Líquido Ascítico/patología , Carcinoma de Ehrlich/metabolismo , Carcinoma de Ehrlich/patología , Adhesión Celular/efectos de los fármacos , Metaloproteinasas de la Matriz/metabolismo , Ratones , Cavidad Peritoneal/patología
9.
Br J Cancer ; 80(1-2): 17-24, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10389972

RESUMEN

The cytotoxicity of two compounds described as anti-angiogenic, the isoflavone genistein and the oestrogen metabolite 2-methoxyestradiol, has been studied in different human tumour cell lines. Since the degradation of the extracellular matrix is one of the essential steps in angiogenesis, the potential modulatory effects of both compounds on the proteolytic balance in media conditioned by different human tumour cells have been also investigated. The IC50 values for 2-methoxyestradiol were lower than those for genistein on all the cell lines tested. In all the cell lines expressing measurable amounts of active enzymes, genistein induced a shift towards antiproteolysis in both matrix metalloproteinase/tissue inhibitor of metalloproteinase and urokinase/plasminogen activator inhibitor proteolytic balances. On the other hand, 2-methoxyestradiol did not produce any clear net shift of the proteolytic balance, with the significant exception of the matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in WAC-2 cells, a neuroblastoma cell line with enhanced expression of the N-myc oncogene.


Asunto(s)
Antineoplásicos/farmacología , Endopeptidasas/fisiología , Estradiol/análogos & derivados , Proteínas de la Matriz Extracelular/efectos de los fármacos , Genisteína/farmacología , Péptido Hidrolasas/farmacología , Inhibidores de Proteasas/farmacología , 2-Metoxiestradiol , División Celular/efectos de los fármacos , Colagenasas/fisiología , Medios de Cultivo Condicionados , Endopeptidasas/efectos de los fármacos , Estradiol/farmacología , Proteínas de la Matriz Extracelular/fisiología , Gelatinasas/fisiología , Humanos , Metaloproteinasa 2 de la Matriz , Metaloproteinasa 3 de la Matriz/fisiología , Metaloproteinasa 9 de la Matriz , Metaloendopeptidasas/fisiología , Inactivadores Plasminogénicos/fisiología , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Inhibidores Tisulares de Metaloproteinasas/fisiología , Células Tumorales Cultivadas , Activador de Plasminógeno de Tipo Uroquinasa/fisiología
10.
Biochem Pharmacol ; 57(12): 1341-4, 1999 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-10353253

RESUMEN

Mammalian ornithine decarboxylase and histidine decarboxylase present common structural and functional features, and their products also share pharmacological and physiological properties. Although accumulated evidence pointed for years to a direct involvement of polyamines and histamine in tumour growth, it has been only in the last few years that new molecular data have contributed to the clarification of this topic. The aim of this commentary is to review the molecular grounds of the role of histamine and polyamines in cancer and to point to possible directions for future research in emerging areas of interest.


Asunto(s)
Histamina/metabolismo , Neoplasias/metabolismo , Poliaminas/metabolismo , Animales , Descarboxilasas de Aminoácido-L-Aromático/química , Descarboxilasas de Aminoácido-L-Aromático/metabolismo , División Celular , Diaminas/metabolismo , Progresión de la Enfermedad , Humanos , Invasividad Neoplásica , Neoplasias/enzimología , Neoplasias/patología , Neovascularización Patológica
11.
Cancer Lett ; 132(1-2): 45-50, 1998 Oct 23.
Artículo en Inglés | MEDLINE | ID: mdl-10397452

RESUMEN

The activity of AV200, a synthetic ardeemin derivative, in reversing the multidrug resistance phenotype has been investigated. At non-toxic doses, AV200 was able to completely restore vincristine and paclitaxel toxicities and partially restore that of doxorubicin in multidrug-resistant cells. The potency of AV200 as a modulator of the resistance to doxorubicin, vincristine and paclitaxel resulted to be seven-, 59 and 12-fold, respectively, higher than that of verapamil. In vitro measurements of rhodamine 123 accumulation in human resistant cells suggest that AV200 reverses multidrug resistance by directly inhibiting the P-glycoprotein-mediated drug efflux. This work underscores the possibility of utilizing ardeemin derivatives as a source of non-toxic modulators of the multidrug resistance phenotype.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/efectos de los fármacos , Antineoplásicos/farmacología , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Compuestos Heterocíclicos con 3 Anillos/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/fisiología , Animales , Bloqueadores de los Canales de Calcio/farmacología , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Doxorrubicina/farmacología , Humanos , Paclitaxel/farmacología , Rodamina 123/farmacocinética , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Verapamilo/farmacología , Vincristina/farmacología
12.
Clin Exp Metastasis ; 15(1): 26-32, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9009103

RESUMEN

To measure matrix metalloproteinase (MMP) activity in a large number of samples it is advisable to use easily automated methods. We have evaluated and compared the activity of stromelysin-1 (MMP-3), matrilysin (MMP-7), 72 kDa gelatinase A (MMP-2) and 92 kDa gelatinase B (MMP-9) by zymogram analysis and fluorescent substrate degradation assays. FITC-casein and the fluorogenic peptide Dnp-Pro-beta-cyclo-hexyl-Ala-Gly-Cys(Me)-His-Ala-Lys-(N-Me-Abz)-NH 2 were used as fluorescent substrates. FITC-casein was more efficiently degraded than the fluorogenic peptide by all MMPs tested except MMP-9. MMP-2 was not significantly able to degrade the fluorogenic peptide. Gelatin zymography was the most sensitive method to detect the activity of both gelatinases but quantitation problems compromise its use. The degradation of fluorogenic substrates by MMPs could be inhibited by the chelating agent EDTA and by the tissue inhibitor of metalloproteinases 2 (TIMP-2), an MMP-specific inhibitor. Fluorometric methods represent a good alternative for MMP activity measurement, especially when a large number of samples must be processed.


Asunto(s)
Colagenasas/análisis , Electroforesis en Gel de Poliacrilamida , Fluorometría , Gelatinasas/análisis , Metaloproteinasa 3 de la Matriz/análisis , Metaloendopeptidasas/análisis , Proteínas Recombinantes de Fusión/análisis , Calcio/fisiología , Caseínas/metabolismo , Quelantes/farmacología , Colagenasas/metabolismo , Ácido Edético/farmacología , Inhibidores Enzimáticos/farmacología , Fluoresceína-5-Isotiocianato , Colorantes Fluorescentes , Gelatinasas/antagonistas & inhibidores , Gelatinasas/metabolismo , Humanos , Metaloproteinasa 3 de la Matriz/metabolismo , Metaloproteinasa 7 de la Matriz , Metaloproteinasa 9 de la Matriz , Inhibidores de la Metaloproteinasa de la Matriz , Metaloendopeptidasas/antagonistas & inhibidores , Metaloendopeptidasas/metabolismo , Proteínas/farmacología , Proteínas Recombinantes de Fusión/antagonistas & inhibidores , Inhibidor Tisular de Metaloproteinasa-2
13.
Arch Biochem Biophys ; 334(2): 241-50, 1996 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-8900398

RESUMEN

The reaction of the sulfhydryl groups in metallothionein with hydrogen peroxide was examined in HL-60 cells. Partial purification of cell cytosol using Sephadex G-75 chromatography showed that zinc-metallothionein (Zn-MT) was induced by 24-h treatment with 100 microM ZnCl2, but the cellular glutathione content and glutathione peroxidase and catalase activities were unaffected. The ratio of H202 concentrations needed to reduce cell survival 50% in Zn-induced cells compared to normal cells was 1.65 to 1. According to alkaline elution experiments, the average ratio of single-strand breaks caused by H202 at 37 degrees C in Zn-induced vs normal cells was 0.5 to 1. A similar reduction in strand breakage was seen in nuclei from Zn-treated cells exposed to H202; however, at 4 degrees C protection against DNA strand breakage by Zn pretreatment was not seen. Incubation of Zn-pretreated cells with H202 at 37 degrees C but not 4 degrees C was accompanied by loss of Zn bound to MT and a reduction in the number of MT sulfhydryl groups. In the absence or presence of Zn-MT, sulfhydryl groups from glutathione and protein fractions were also reduced by exposure of cells to H202. However, thiolate groups in the MT fraction were preferentially lost compared to the other pools of sulfhydryl residues. Zn-MT also spared glutathione sulfhydryl groups in vitro from oxidation by H202. Protection against strand breakage correlated with the ability of Zn-MT to react in vitro with H202 at 37 degrees C, but not at 4 degrees C. The reaction was slow and was not inhibited by the presence of an hydroxyl radical scavenger, dimethyl sulfoxide. Similarly, in cells dimethyl sulfoxide did not prevent the loss of sulfhydryl groups from glutathione or protein. Incubation of MT or higher molecular weight fractions from cells exposed to H202 with either 2-mercaptoethanol or dithiothreitol in the presence of Cd failed to regenerate any detectable, reduced MT, suggesting that MT sulfhydryl groups were oxidized by H202 beyond the disulfide oxidation state.


Asunto(s)
Peróxido de Hidrógeno/metabolismo , Metalotioneína/metabolismo , Zinc/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Cromatografía en Gel , Cromatografía por Intercambio Iónico , Daño del ADN , Reparación del ADN , Glutatión/metabolismo , Células HL-60 , Humanos , Peróxido de Hidrógeno/farmacología , Cinética , Hígado/metabolismo , Metalotioneína/química , Metalotioneína/aislamiento & purificación , Conejos , Compuestos de Sulfhidrilo
14.
Br J Cancer ; 74(5): 677-82, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8795567

RESUMEN

The effects of several members of the family of lamellarins, polyaromatic alkaloids isolated from tunicates belonging to the genus Didemnum, on the growth of several tumour cell lines and on P-glycoprotein (P-gp)-mediated multidrug resistance (MDR), were investigated. Cytotoxicity experiments of lamellarins were performed on a panel of tumour cell lines, including two multidrug-resistant cell lines. Some lamellarins showed good anti-tumour activity, with similar levels of cytotoxicity against both the resistant and their corresponding parental cell lines. Two lamellarins displayed a high potency against lung carcinoma cells. Studies of the resistance modifier activity of the different lamellarins at non-toxic concentrations were also carried out in cells exhibiting MDR, and lamellarin I was selected for the highest chemosensitising activity. At non-toxic doses, verapamil and lamellarin I effectively increased the cytotoxicity of doxorubicin, vinblastine and daunorubicin in a concentration-dependent manner in multidrug-resistant cells, but the potency of lamellarin I as a MDR modulator was 9- to 16-fold higher than that of verapamil. In vitro measurements of rhodamine 123 accumulation in the multidrug-resistant Lo Vo/Dx cells suggest that lamellarin I reverses MDR by directly inhibiting the P-gp-mediated drug efflux. This work underscores the possibility of using these marine-derived compounds as a potential new source of anti-tumoral drugs active on resistant cells as well as of non-toxic modulators of the MDR phenotype.


Asunto(s)
Alcaloides/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Neoplasias del Colon/tratamiento farmacológico , Resistencia a Múltiples Medicamentos/fisiología , Leucemia P388/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/fisiología , Adenocarcinoma/tratamiento farmacológico , Alcaloides/química , Alcaloides/farmacología , Animales , Antimetabolitos Antineoplásicos/metabolismo , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Supervivencia Celular/efectos de los fármacos , Cricetinae , Daunorrubicina/administración & dosificación , Doxorrubicina/administración & dosificación , Resistencia a Antineoplásicos/fisiología , Humanos , Ratones , Rodamina 123 , Rodaminas/metabolismo , Células Tumorales Cultivadas , Verapamilo/administración & dosificación , Vinblastina/administración & dosificación
15.
Cancer Lett ; 105(1): 29-32, 1996 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-8689628

RESUMEN

Glutamine, glutamate, asparagine, and aspartate contents in mouse kidney during Ehrlich ascites carcinoma development were determined. Significant changes in the concentrations of these amino acids were observed only 24 h after tumour inoculation, and they were highest during the exponential phase of tumour growth. These data agree with other previously reported studies and point to a potential of tumour cells to modulate host metabolism for its benefit. Discussed under this hypothesis, the new data reported here seem to indicate that there is an increase in the mobilization of the amino acids studied in mice kidney to provide Ehrlich tumour cells with sources of nitrogen (asparagine and glutamine) which they consume avidly.


Asunto(s)
Asparagina/metabolismo , Carcinoma de Ehrlich/metabolismo , Carcinoma/metabolismo , Glutamina/metabolismo , Riñón/metabolismo , Animales , Carcinoma/patología , Carcinoma de Ehrlich/patología , Ratones
16.
J Biotechnol ; 46(3): 235-41, 1996 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-8672291

RESUMEN

The baculovirus expression system was used to produce recombinant human matrilysin. Expression of promatrilysin reached a peak at 72 h post-infection. Most of the recombinant protein remained in the intracellular fraction in an insoluble form, which after renaturation was purified by S-Sepharose and Green A Dyematrex chromatography in order to remove host proteases. Active recombinant matrilysin degraded casein, type I and type IV collagens and fibronectin. Expression of recombinant human matrilysin using the baculovirus system represents a useful tool for obtaining large amounts of this metalloproteinase in order to carry out further biochemical studies and to screen for inhibitors.


Asunto(s)
Baculoviridae/genética , Expresión Génica , Metaloendopeptidasas/genética , Metaloendopeptidasas/aislamiento & purificación , Animales , Secuencia de Bases , Línea Celular , Neoplasias del Colon , ADN Complementario/química , Humanos , Metaloproteinasa 7 de la Matriz , Metaloendopeptidasas/biosíntesis , Metaloendopeptidasas/metabolismo , Datos de Secuencia Molecular , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Spodoptera , Transfección , Células Tumorales Cultivadas
17.
Lett Appl Microbiol ; 22(4): 303-6, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8934791

RESUMEN

A simple, rapid, sensitive and automatizable method for the detection and quantification of bacterial cell wall inhibitors has been developed. The procedure is characterized by the use of a micro-organism hypersensitive to beta-lactam antibiotics that contains an inducible cytosolic beta-galactosidase; this enzyme is released when the micro-organism cell wall is disrupted by the antibiotic action, and then measured by the use of a chromogenic substrate. The present method allows the detection of beta-lactam traces in other non-beta-lactam antibiotics, and has been successfully applied in the detection of small amounts of beta-lactams in biological fluids such as milk and Actinomycetes fermentation broths. The easy automatization of this method makes it specially suitable for the screening of new antibiotics of natural origin.


Asunto(s)
Antibacterianos/análisis , beta-Lactamas/análisis , Animales , Antibacterianos/farmacología , Bovinos , Evaluación Preclínica de Medicamentos , Escherichia coli/efectos de los fármacos , Escherichia coli/enzimología , Fermentación , Leche , Penicilina G/análisis , Sensibilidad y Especificidad , Streptomyces/metabolismo , beta-Galactosidasa/metabolismo , beta-Lactamas/farmacología
19.
Cancer Lett ; 99(1): 109-14, 1996 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-8564921

RESUMEN

Two methods based on the reversion of adriamycin-resistance o the increase of Rhodamine 123 accumulation in a multidrug resistant (MDR) cell line have been simplified and adapted for the screening of MDR reversal agents. Both methods are carried out in microtiter plates, are highly sensitive and can be easily automated. In both assays verapamil and the cyclosporine derivative PSC 833 could be detected at concentrations lower than 1 and 0.05 microM, respectively. Depending on the MDR cell line used, drugs exhibiting the collateral sensitivity phenomenon can be selected in the cytotoxicity assay, while interferences due to sample toxicity are easily avoided in the dye accumulation assay.


Asunto(s)
Antibióticos Antineoplásicos/farmacología , Doxorrubicina/farmacología , Resistencia a Múltiples Medicamentos , Ensayos de Selección de Medicamentos Antitumorales/métodos , Colorantes Fluorescentes/farmacocinética , Rodaminas/farmacocinética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/metabolismo , Animales , Antibióticos Antineoplásicos/farmacocinética , Antimetabolitos Antineoplásicos/farmacocinética , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/metabolismo , Ciclosporinas/farmacología , Doxorrubicina/farmacocinética , Humanos , Leucemia P388/tratamiento farmacológico , Leucemia P388/metabolismo , Ratones , Rodamina 123 , Verapamilo/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA